UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

14 May 2024

New data published in the Journal of Neurology show clinically meaningful improvement of fatigue in generalized myasthenia gravis (gMG) with ZILBRYSQ[®]▼ (zilucoplan)

Read More
10 May 2024

Acquisition of own shares

Read More
8 May 2024

UCB presents final open-label extension FINTEPLA®▼(fenfluramine)[1] data at International Child Neurology Congress (ICNC) Annual Meeting

Read More
3 May 2024

Acquisition of own shares

Read More
26 Apr 2024

Acquisition of own shares

Read More
25 Apr 2024

UCB’s General Meeting of Shareholders 2024

Read More

Stay up-to-date on the latest news and information from UCB